4
Changes in Ownership
Xenon Pharmaceuticals Inc. Filed Acc 0001209191-21-035911
CEO gave up 5,076 shares (to pay taxes)
- CEO acquired 22,633 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
PIMSTONE SIMON N. · CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-05-24 | Exercise or conversion : show line 1 in the form | +22,633 | $3.76 | $85,100 | 232,819 | D |
| 2021-05-24 | Shares withheld for taxes : show line 2 in the form | −5,076 | $19.17 | $97,307 | 227,743 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-05-24 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −22,633 | 0 | D |
Loading xslF345X03/doc4.xml…